Michael Mannion
12Patents
2h-index
27Co-inventors
46Inventor score
Filing activity: May 19, 2006 → Jul 19, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8404846B2 | Inhibitors of protein tyrosine kinase activity | Human Necessities | 8 | Active |
| US8907091B2 | Processes and intermediates for preparing fused heterocyclic kinase inhibitors | Chemistry; Metallurgy | 6 | Active |
| US8093264B2 | Fused heterocycles as inhibitors of VEGF receptor and HGF receptor signaling | Human Necessities | 2 | Active |
| US7790729B2 | Inhibitors of VEGF receptor and HGF receptor signaling | Human Necessities | 1 | Active |
| US9018378B2 | Processes and intermediates for preparing fused heterocyclic kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US8389541B2 | Inhibitors of protein tyrosine kinase activity | Human Necessities | 0 | Active |
| US8906852B2 | Inhibitors of protein tyrosine kinase activity | Chemistry; Metallurgy | 0 | Active |
| US8729268B2 | Inhibitors of protein tyrosine kinase activity | Chemistry; Metallurgy | 0 | Active |
| US8759522B2 | Inhibitors of protein tyrosine kinase activity | Chemistry; Metallurgy | 0 | Active |
| US8440643B2 | Inhibitors of beta-lactamase | Chemistry; Metallurgy | 0 | Active |
| US8329726B2 | Inhibitors of VEGF receptor and HGF receptor signaling | Human Necessities | 0 | Active |
| US8846927B2 | Inhibitors of protein tyrosine kinase activity | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.